Doris Reid, APRN
Family · Simpsonville, SCNPI 1376099887
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 53.2% of the total. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 426 payments — averaging $59.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$14K
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$1K
- AbbVie$1K
- plus $5K from 21 others
What the payments were for
- Consulting fees$1,4976%
- Speaking & faculty fees$10,42041%
- Travel & lodging$8813%
- Food & beverage$12,26448%
- Education$3091%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 77 | $13,501 |
| Neurocrine Biosciences, Inc. | 82 | $1,629 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $1,466 |
| Otsuka America Pharmaceutical, Inc. | 22 | $1,229 |
| E.r. Squibb & Sons, L.L.C. | 15 | $1,221 |
| AbbVie | 48 | $1,176 |
| Vanda Pharmaceuticals Inc. | 27 | $1,014 |
| Alkermes, Inc. | 25 | $745 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $664 |
| Johnson & Johnson | 16 | $600 |
| Alnylam Pharmaceuticals Inc. | 2 | $240 |
| Indivior Inc. | 8 | $237 |
| Ironshore Pharmaceuticals Inc. | 7 | $218 |
| Almatica Pharma LLC | 20 | $198 |
| Lundbeck LLC | 9 | $164 |
| Supernus Pharmaceuticals, Inc. | 7 | $139 |
| AstraZeneca | 1 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Viatris Specialty LLC | 1 | $108 |
| Amgen | 1 | $99 |
| Sanofi-aventis U.S. LLC | 1 | $93 |
| Acadia Pharmaceuticals Inc | 1 | $81 |
| Noven Therapeutics, LLC | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $46 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$11,351
- ABILIFY ASIMTUFII$912
- CAPLYTA$760
- Fanapt$599
- LYBALVI$497
- VRAYLAR$474
- ARISTADA$408
- ABILIFY MAINTENA$368
- INGREZZA$253
- AUSTEDO$230
- INVEGA SUSTENNA$230
- REXULTI$222
- FARXIGA$135
- Auvelity$124
- GIVLAARI$123
- Rinvoq$123
- AMVUTTRA$117
- Austedo XR$116
- COBENFY$112
- Yupelri$108
How this compares
$25,371 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 35 | $195,276 |
| Austedo XrDeutetrabenazine | 25 | $181,318 |
| VraylarCariprazine Hcl | 59 | $87,528 |
| RexultiBrexpiprazole | 39 | $76,600 |
| AristadaAripiprazole Lauroxil | 15 | $57,802 |
| TrintellixVortioxetine Hydrobromide | 33 | $39,794 |
| CaplytaLumateperone Tosylate | 21 | $39,076 |
| Invega SustennaPaliperidone Palmitate | 12 | $37,518 |
| Lurasidone Hcl | 65 | $20,620 |
| BelsomraSuvorexant | 33 | $14,613 |
| QuviviqDaridorexant Hcl | 15 | $8,048 |
| VyvanseLisdexamfetamine Dimesylate | 16 | $6,319 |
| Aripiprazole | 53 | $3,062 |
| Clozapine | 20 | $2,097 |
| Lamotrigine ErLamotrigine | 12 | $2,040 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $13,501 | $376,59460 claims |
| AbbVieVraylar | $1,176 | $87,52859 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,229 | $76,60039 claims |
| Alkermes, Inc.Aristada | $745 | $57,80215 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $132 | $46,11349 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,466 | $39,07621 claims |
| Johnson & JohnsonInvega Sustenna | $600 | $37,51812 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $46 | $8,04815 claims |
| Almatica Pharma LLCSertraline Hcl | $198 | $28663 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.
Other family in Simpsonville
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Hailey AtkinsonIrmo$24K
- Devon DriverColumbia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.